Skip to main content
. Author manuscript; available in PMC: 2013 Sep 4.
Published in final edited form as: Eur J Pharmacol. 2011 Mar 31;668(3):428–434. doi: 10.1016/j.ejphar.2011.03.022

Table 1.

Cell viability of PMNs after N-ac-PGP, PGG and LPS incubation.

1 h 2 h 4 h 6 h 8 h 19 h 24 h
Control
%PMNs 95.7 95.6 95.5 94.3 93.0 86.2 76.4
% PI+ PMNs 2.7 1.9 2.3 2.8 3.9 21.5 41.6
N-ac-PGP 3 × 10−4 M
%PMNs 96.7 96.6 95.6 95.0 94.7 87.3 78.7
% PI+ PMNs 2.2 2.0 2.7 2.5 3.5 24.9 49.4
N-ac-PGP 10−3 M
%PMNs 97.0 96.6 95.9 94.8 94.9 89.8 84.1
% PI+ PMNs 2.0 1.9 2.4 2.4 3.9 19.5 45.8
N-ac-PGP 3 × 10−3 M
%PMNs 96.9 96.5 95.7 95.1 95.1 91.5 87.4
% PI+ PMNs 2.1 2.0 2.1 2.6 3.3 13.2 34.2
PGG 3 × 10−3 M
%PMNs 97.1 96.5 96.3 94.5 93.7 86.7 76.6
% PI+ PMNs 2.0 2.0 2.1 2.6 3.0 22.9 45.4
LPS 1 µg/ml
%PMNs 86.0 94.2 90.7 88.3 86.9 60.5 47.4
% PI+ PMNs 9.1 4.2 5.5 6.0 9.2 49.8 74.4

7 × 105 buffy coat isolated PMNs resuspended in 300 µl RPMI medium with 1% FCS were loaded with 3 µl PI (5 µg/ml). A gate based on PMNs physical parameters (forward and side scatter) was set to exclude debris. Within this gate, the PI positive population was monitored in the FL2 channel.